Laidlaw Wealth Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$870K Buy
946
+98
+12% +$99.4K 3.02% 9
2025
Q4
$911K Hold
848
2.82% 10
2025
Q3
$647K Sell
848
-47
-5% -$35K 1.54% 22
2025
Q2
$698K Sell
895
-1
-0.1% -$777 2.01% 16
2025
Q1
$740K Sell
896
-982
-52% -$817K 2.18% 14
2024
Q4
$1.45M Buy
1,878
+149
+9% +$123K 0.63% 43
2024
Q3
$1.53M Buy
1,729
+343
+25% +$308K 0.76% 40
2024
Q2
$1.25M Sell
1,386
-12
-0.9% -$9.6K 0.69% 45
2024
Q1
$1.09M Sell
1,398
-1,379
-50% -$981K 0.61% 51
2023
Q4
$1.62M Buy
2,777
+289
+12% +$169K 0.59% 42
2023
Q3
$1.34M Sell
2,488
-220
-8% -$113K 0.44% 66
2023
Q2
$1.27M Sell
2,708
-1,247
-32% -$523K 0.25% 99
2023
Q1
$1.36M Buy
3,955
+446
+13% +$150K 0.28% 97
2022
Q4
$1.28M Buy
3,509
+1,453
+71% +$515K 0.28% 100
2022
Q3
$665K Buy
2,056
+465
+29% +$147K 0.16% 148
2022
Q2
$516K Sell
1,591
-643
-29% -$193K 0.11% 195
2022
Q1
$640K Buy
2,234
+1,169
+110% +$301K 0.11% 187
2021
Q4
$294K Buy
+1,065
New +$270K 0.05% 312

Other funds holding LLY

Laidlaw Wealth Management's LLY Position: Q1 2026 in Review

Laidlaw Wealth Management increased its Eli Lilly (LLY) stake by 12% in Q1 2026, buying an estimated $99.4K and bringing the position to 946 shares worth $870K. The position accounts for 3.02% of the portfolio, ranked #9.

Laidlaw Wealth Management first reported a position in LLY in Q4 2021 and has held it in 18 quarters since. The position peaked at $1.62M in Q4 2023. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Laidlaw Wealth Management held 946 shares of Eli Lilly worth $870K as of Q1 2026.
  • Laidlaw Wealth Management bought 98 Eli Lilly shares in Q1 2026, an estimated $99.4K.
  • Eli Lilly made up 3.02% of Laidlaw Wealth Management's portfolio in Q1 2026, its #9 holding.
  • Laidlaw Wealth Management first reported a position in Eli Lilly in Q4 2021 and has held it in 18 quarters since.
  • Laidlaw Wealth Management's Eli Lilly position peaked at $1.62M in Q4 2023.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Laidlaw Wealth Management's 13F filing for Q1 2026, filed 6 May 2026.